12,000
Participants
Start Date
June 11, 2025
Primary Completion Date
February 2, 2032
Study Completion Date
February 2, 2032
V181
Participants will receive a single 0.5 mL SC dose of V181 on Day 1.
Placebo
Participants will receive a single 0.5 mL SC dose of placebo on Day 1.
RECRUITING
Philippine General Hospital ( Site 0041), Manila
RECRUITING
University of the Philippines Manila ( Site 0047), Metro Manila
RECRUITING
Health Index Multispecialty And Lying-In Clinic ( Site 0042), Bacoor
ACTIVE_NOT_RECRUITING
West Visayas State University Medical Center ( Site 0045), Iloilo City
RECRUITING
Chong Hua Hospital ( Site 0051), Cebu City
RECRUITING
Norzel Medical and Diagnostic Clinic Foundation Corp ( Site 0044), Cebu City
RECRUITING
Chulalongkorn University-Pediatrics ( Site 0063), Bangkok
RECRUITING
Faculty of Tropical Medicine, Mahidol University ( Site 0062), Bangkok
RECRUITING
Faculty of Tropical Medicine, Mahidol University - Vaccine Trial Centre ( Site 0067), Ratchathewi
RECRUITING
Faculty of Medicine Siriraj Hospital-Pediatric Infectious Diseases ( Site 0065), Bangkok
RECRUITING
Thammasat University Hospital-Department of Pediatrics ( Site 0068), Khong Luang
RECRUITING
Faculty of Medicine - Khon Kaen University-Pediatrics ( Site 0064), Amphoe Mueang
RECRUITING
Sunway Medical Centre ( Site 0027), Petaling Jaya
RECRUITING
Hospital Tunku Azizah-Paediatric ( Site 0022), Kuala Lumpur
RECRUITING
University Malaya Medical Centre-Department of Paediatrics ( Site 0025), Lembah Pantai
RECRUITING
Hospital Ampang ( Site 0028), Ampang
RECRUITING
Songklanagarind hospital-Department of Pediatrics ( Site 0061), Hat Yai
RECRUITING
Hospital Sibu ( Site 0021), Sibu
RECRUITING
National University Hospital-Paediatrics ( Site 0001), Singapore
RECRUITING
KK Women's and Children's Hospital ( Site 0002), Singapore
RECRUITING
Tan Tock Seng Hospital ( Site 0003), Singapore
Merck Sharp & Dohme LLC
INDUSTRY